Screener
Ligand Pharmaceuticals LGND Gain (loss) on disposal of assets
Gain (loss) on disposal of assets at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnInvestments.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
| Line item | Three months ended / June 30, 2026 | Three months ended / June 30, 2025 | Six months ended / June 30, 2026 | Six months ended / June 30, 2025 |
|---|---|---|---|---|
| Total operating costs and expenses | 55,102 | 39,183 | 89,456 | 120,732 |
| Operating income (loss) | 8,591 | 8,444 | 25,959 | (27,772) |
| Non-operating income and expenses: | ||||
| Gain (loss) from short-term investments | 11,754 | 939 | 15,623 | (11,428) |
| Gain (loss) from change in fair value of equity-method investments and other investments | 35,727 | — | (13,502) | — |
| Interest income | 7,298 | 1,621 | 13,953 | 3,392 |
| Interest expense | (1,748) | (1,153) | (3,495) | (2,020) |
| Other non-operating expense, net | 2,682 | 1,372 | 1,507 | (1,129) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Ligand Pharmaceuticals's gain (loss) on disposal of assets?
- Ligand Pharmaceuticals (LGND) reported gain (loss) on disposal of assets of $11.75M in Q2 2026.
- How has Ligand Pharmaceuticals's gain (loss) on disposal of assets changed year-over-year?
- Ligand Pharmaceuticals's gain (loss) on disposal of assets increased by 1151.8% year-over-year, from $939K to $11.75M.
- What is the long-term trend for Ligand Pharmaceuticals's gain (loss) on disposal of assets?
- Over 3 years (2021 to 2025), Ligand Pharmaceuticals's gain (loss) on disposal of assets has grown at a -100.0% compound annual growth rate (CAGR), from -$1K to $0.
- What does gain (loss) on disposal of assets mean?
- Gains or losses recognized on the disposal of businesses, property, equipment, investments, or other assets at prices above or below their carrying value.
Ask your AI about Ligand Pharmaceuticals's gain (loss) on disposal of assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude